|
|
|
| Name |
| Alves, Pedro M. S. |
|
| Nationality |
| Portuguese |
| E-Mail |
| alvespms@yahoo.co.uk |
|
| 1st Degree |
| Biology |
|
| University (1st Degree) |
| Oporto University |
|
| About the PhD |
| Field of Research |
| Tumor Immunology |
|
| Supervisor(s) |
| Kostas Kosmatopoulos, MD |
|
| Co-Supervisor(s) |
| Eduardo Guimaraes MD PhD; Angelo A Cardoso MD PhD |
|
| University |
| Porto |
|
| Laboratory |
| Dana-Farber Cancer Research (USA); INSERM (FRANCE); Ludwig Inst. For Cancer Research (SWITZERLAND); Inst. Suisse pour la Recherche du Cancer (SWITZERLAND); Univ. Catholique de Louvain - Inst. Christian de Duve (BELGIUM) |
|
| Date of Thesis Defence |
| 2003-03-27 |
|
| After the PhD (Current Situation) |
| Position |
| Head Clinical Immunology, Cancer Immunotherapeutics BU. |
|
| Institution |
| GlaxoSmithKline Vaccines |
| View Institution website |
|
| City |
| Rixensart |
|
| Country |
| Belgium |
|
|
| Relevant Publications |
|
| ALVES PM, FAURE O, GRAFF-DUBOIS S, GROSS DA, CORNET S, CHOUAIB S, MICONNET I, LEMONNIER FA, KOSMATOPOULOS K. EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. Cancer Res. 2003 Dec 1;63(23):8476-80. |
|
| PEDRO MS ALVES, OLIVIER FAURE, STEPHANIE GRAFF-DUBOIS, SEBASTIEN CORNET, IRENA BOLONAKIS, DAVID-ALEXANDRE GROSS, ISABELLE MICONNET, SALEM CHOUAIB, FRANCOIS A LEMONNIER, KOSTAS KOSMATOPOULOS. STEAP, an overexpressed tumor antigen of prostate, can be target of human CD8+ T cells. Cancer Immunology Immunotherapy, in press. |
|
Alves PM, Levy N, Bouzourene H, Viatte S, Bricard G, Ayyoub M, Vuilleumier H, Givel JC, Halkic N, Speiser DE, Romero P, Levy F.
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer.
Cancer Immunol Immunother. 2007 Jun;56(6):839-47 |
|
Alves PM, Viatte S, Fagerberg T, Michielin O, Bricard G, Bouzourene H, Vuilleumier H, Kruger T, Givel JC, Levy F, Speiser DE, Cerottini JC, Romero P.
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
Cancer Immunol Immunother. 2007 Nov;56(11):1795-805 |
|
Viatte S, Alves PM, Romero P.
Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.
Immunol Cell Biol. 2006 Jun;84(3):318-30 |
| Publications |
|
| CARVALHO F, DAVID L, AUBERT JP, LOPEZ-FERRER A, DE BOLOS C, REIS CA, GARTNER F, PEIXOTO A, ALVES P, SOBRINHO-SIMOES M.Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines.Virchows Arch. 1999 Nov;435(5):479-85. |
|
| P ALVES, P SOARES, E FONSECA, M SOBRINHO-SIMOES. Papillary thyroid carcinoma overexpressed fully and underglycosylated mucins together with native and sialylated simple mucins antigens and histoblood group antigens. Endocrine Pathology. 1999; 10: 315 -324 |
|
| P ALVES, P SOARES, S ROSSI, E FONSECA, M SOBRINHO-SIMOES. Clinicopathologic and prognostic significance in the expression of mucins, simple mucins antigens and histoblood group antigens in papillary thyroid carcinoma. Endocrine Pathology. 1999; 10: 305 -314. |
|
| SCARDINO A., ALVES P., GROSS D.A., TOURDOT S., GRAFF-DUBOIS, S., CHOUAIB S., LEMMONIER F., NADLER L.M., CARDOSO A.A., KOSMATOPOULOS K. Identification of Novel HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other epithelial tumors. Eur. J. Immunol. 2001 Nov;31(11):3261-70. |
|
| SCARDINO A, GROSS DA, ALVES P, SCHULTZE JL, GRAFF-DUBOIS S, FAURE O, TOURDOT S, CHOUAIB S, NADLER LM, LEMONNIER FA, VONDERHEIDE RH, CARDOSO AA, KOSMATOPOULOS K. HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. J Immunol. 2002 Jun 1;168(11):5900-6. |
[more publications]
| More Publications |
|
| SCARDINO A, CORREALE P, FIRAT H, PELLEGRINI M, KOSMATOPOULOS K, OPOLON P, ALVES P, ZURBRIGGEN R, GLUCK R, LEMONNIER FA, FRANCINI G, CUSI MG. In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse. Br J Cancer. 2003 Jul 7;89(1):199-205. |
|
| GROSS DA, GRAFF-DUBOIS S, OPOLON P, CORNET S S, ALVES P, BENNACEUR-GRISCELLI A, FAURE O, GUILLAUME P, FIRAT H H, CHOUAIB S, LEMONNIER FA, DAVOUST J, MICONNET I, VONDERHEIDE RH, KOSMATOPOULOS K. High vaccination efficiency of low-affinity epitopes in anti-tumor immunotherapy. J Clin Invest. 2004 Feb;113(3):425-33. |
|
| FAURE O, GRAFF-DUBOIS S, BRETAUDEAU L, DERRE L, GROSS DA, ALVES PM, CORNET S, DUFFOUR MT, CHOUAIB S, MICONNET I, GREGOIRE M, JOTEREAU F, LEMONNIER FA, ABASTADO JP, KOSMATOPOULOS K. Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes. Int J Cancer. 2004 Mar 1;108(6):863-70. |
|
| GROSS DA, GRAFF-DUBOIS S, OPOLON P, CORNET S, ALVES P, BENNACEUR-GRISCELLY A, FAURE O, GUILLAUME P, FIRAT H, CHOUAIB S, LEMONNIER FA, DAVOUST J, MICONNET I, VONDERHEIDE RH, KOSMATOPOULOS K. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J Clin Invest. 2004 Feb;113(3):425-33. |
|
| HAINING WN, ANDERSON DG, LITTLE SR, VON BERWELT-BAILDON MS, CARDOSO AA, ALVES P, KOSMATOPOULOS K, NADLER LM, LANGER R, Kohane DS. pH-triggered microparticles for peptide vaccination. J Immunol. 2004 Aug 15;173(4):2578-85. |
|
| Michielin O, Blanchet JS, Fagerberg T, Valmori D, Rubio-Godoy V, Speiser D, Ayyoub M, Alves P, Luescher I, Gairin JE, Cerottini JC, Romero P. Tinkering with nature: the tale of optimizing peptide based cancer vaccines. Cancer Treat Res. 2005;123:267-91. Review. |
|
| MARCO MIGLIACCIO, PEDRO MS ALVES, PEDRO ROMERO, NATHALIE RUFER. Distinct mechanisms control human naive and antigen-experienced CD8+ T lymphocyte proliferation. J Immunol. 2006; 176: 2173-82. |
| Last Update |
| 2013-03-18 16:24:34 |
| The responsibility for this page contents is entirely of the student/alumnus. |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Program financially supported by
the National Foundation for
Science and Technology
|
|
 |
|
